Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Jan. 02, 2022   152,272,287    
Beginning balance at Jan. 02, 2022 $ 326,117 $ 15 $ 659,254 $ (333,152)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercise of stock options (in shares)   91,910    
Issuance of common stock upon exercise of stock options 200   200  
Issuance of common stock upon exercise of common stock warrants (in shares)   4,126,466    
Issuance of common stock upon exercise of common stock warrants 47,452   47,452  
Early exercised stock option vested 42   42  
RSUs vested (in shares)   34,941    
Repurchase of unvested restricted common stock (in shares)   (105,886)    
Stock-based compensation 4,536   4,536  
Net (loss) income 42,707     42,707
Ending balance (in shares) at Apr. 03, 2022   156,419,718    
Ending balance at Apr. 03, 2022 421,054 $ 15 711,484 (290,445)
Beginning balance (in shares) at Jan. 01, 2023   157,461,802    
Beginning balance at Jan. 01, 2023 $ 356,427 $ 15 741,186 (384,774)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon exercise of stock options (in shares) 86,654 86,654    
Issuance of common stock upon exercise of stock options $ 328   328  
Early exercised stock option vested 83 $ 1 82  
RSUs vested, net of shares withheld for taxes (in shares)   679,606    
RSUs vested, net of shares withheld for taxes (777)   (777)  
Repurchase of unvested restricted common stock (in shares)   (138,599)    
Stock-based compensation 29,653   29,653  
Net (loss) income (73,603)     (73,603)
Ending balance (in shares) at Apr. 02, 2023   158,089,463    
Ending balance at Apr. 02, 2023 $ 312,111 $ 16 $ 770,472 $ (458,377)